Abstract
Background: Gastroesophageal reflux disease is one of the most common chronic diseases, affecting up to 28% of the western population. Therapeutic management ranges from conservative measures to endoscopic or surgical interventions. Laparoscopic Nissen fundoplication (LNF) still is considered as gold standard, but alternative procedures have been developed and evaluated within the past years. Summary: Magnetic sphincter augmentation (MSA), which aims to be a less disruptive and possibly more standardized laparoscopic procedure than LNF, shows satisfying results regarding short- and long-term follow-up as well as comorbidities. Alternatives, such as the RefluxStop™ procedure or Transoral incisionless fundoplication (TIF), combined with laparoscopic hiatal hernia repair (cTIF) show promising results for short-term follow-up, nevertheless further studies regarding long-term follow-up are necessary. Key Message: Although there definitely are upcoming and promising trends in upper GI surgery, LNF still represents today’s gold standard and MSA is an equivalent alternative. RefluxStop™ and cTIF show promising results, nevertheless, further studies are necessary.
Journal Section:
Review Article
References
1.
Danilova
DA
, Bazaev
AV
, Gorbunova
LI
. [Current aspects of surgical treatment of gastro-esophageal reflux disease]
. Khirurgiia
. 2020
(2
):89
–94
. 2.
Schizas
D
, Mastoraki
A
, Papoutsi
E
, Giannakoulis
VG
, Kanavidis
P
, Tsilimigras
D
, et al. LINX® reflux management system to bridge the “treatment gap” in gastroesophageal reflux disease: a systematic review of 35 studies
. World J Clin Cases
. 2020
;8
(2
):294
–305
. 3.
Nguyen
NT
, Thosani
NC
, Canto
MI
, Chang
K
, Lipham
J
, Abu Dayyeh
B
, et al. The American Foregut society white paper on the endoscopic classification of esophagogastric junction integrity
. Foregut
. 2022
;2
(4
):339
–48
. 4.
Dent
J
, Holloway
RH
, Toouli
J
, Dodds
WJ
. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux
. Gut
. 1988
;29
(8
):1020
–8
. 5.
Brewer Gutierrez
OI
, Choi
D
, Hejazi
R
, Samo
S
, Tran
MN
, Chang
KJ
, et al. American Foregut society white paper on transoral incisionless fundoplication
. Foregut
. 2023
;3
(3
):242
–54
. 6.
Felinska
E
, Billeter
A
, Nickel
F
, Contin
P
, Berlth
F
, Chand
B
, et al. Do we understand the pathophysiology of GERD after sleeve gastrectomy
. Ann N Y Acad Sci
. 2020
;1482
(1
):26
–35
. 7.
Eusebi
LH
, Cirota
GG
, Zagari
RM
, Ford
AC
. Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis
. Gut
. 2021
;70
(3
):456
–63
. 8.
Shaheen
N
, Ransohoff
DF
. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applications
. JAMA
. 2002
;287
(15
):1982
–6
. 9.
Galmiche
JP
, Hatlebakk
J
, Attwood
S
, Ell
C
, Fiocca
R
, Eklund
S
, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial
. JAMA
. 2011
;305
(19
):1969
–77
. 10.
Lundell
L
, Bell
M
, Ruth
M
. Systematic review: laparoscopic fundoplication for gastroesophageal reflux disease in partial responders to proton pump inhibitors
. World J Gastroenterol
. 2014
;20
(3
):804
–13
. 11.
Markar
SR
, Arhi
C
, Wiggins
T
, Vidal-Diez
A
, Karthikesalingam
A
, Darzi
A
, et al. Reintervention after antireflux surgery for gastroesophageal reflux disease in England
. Ann Surg
. 2020
;271
(4
):709
–15
. 12.
Richter
JE
. Gastroesophageal reflux disease treatment: side effects and complications of fundoplication
. Clin Gastroenterol Hepatol
. 2013
;11
(5
):465
–e39
quiz e39. 13.
Schwameis
K
, Nikolic
M
, Morales Castellano
DG
, Steindl
A
, Macheck
S
, Kristo
I
, et al. Results of magnetic sphincter augmentation for gastroesophageal reflux disease
. World J Surg
. 2018
;42
(10
):3263
–9
. 14.
Ukegjini
K
, Vetter
D
, Dirr
V
, Gutschow
CA
. Hiatus hernia repair with a new-generation biosynthetic mesh: a 4-year single-center experience
. Surg Endosc
. 2023
;37
(7
):5295
–302
. 15.
Gerdes
S
, Schoppmann
SF
, Bonavina
L
, Boyle
N
, Müller-Stich
BP
, Gutschow
CA
, et al. Management of paraesophageal hiatus hernia: recommendations following a European expert Delphi consensus
. Surg Endosc
. 2023
;37
(6
):4555
–65
. 16.
Oelschlager
BK
, Pellegrini
CA
, Hunter
JG
, Brunt
ML
, Soper
NJ
, Sheppard
BC
, et al. Biologic prosthesis to prevent recurrence after laparoscopic paraesophageal hernia repair: long-term follow-up from a multicenter, prospective, randomized trial
. J Am Coll Surg
. 2011
;213
(4
):461
–8
. 17.
Li
J
, Cheng
T
. Mesh erosion after hiatal hernia repair: the tip of the iceberg
. Hernia
. 2019
;23
(6
):1243
–52
. 18.
Spiro
C
, Quarmby
N
, Gananadha
S
. Mesh-related complications in paraoesophageal repair: a systematic review
. Surg Endosc
. 2020
;34
(10
):4257
–80
. 19.
Abdelmoaty
WF
, Dunst
CM
, Filicori
F
, Zihni
AM
, Davila-Bradley
D
, Reavis
KM
, et al. Combination of surgical technique and bioresorbable mesh reinforcement of the crural repair leads to low early hernia recurrence rates with laparoscopic paraesophageal hernia repair
. J Gastrointest Surg
. 2020
;24
(7
):1477
–81
. 20.
Konstantinidis
H
, Charisis
C
. Surgical treatment of large and complicated hiatal hernias with the new resorbable mesh with hydrogel barrier (Phasix ST): a preliminary study
. J Robot Surg
. 2023
;17
(1
):141
–6
. 21.
Panici Tonucci
T
, Asti
E
, Sironi
A
, Ferrari
D
, Bonavina
L
. Safety and efficacy of crura augmentation with Phasix ST mesh for large hiatal hernia: 3-year single-center experience
. J Laparoendosc Adv Surg Tech
. 2020
;30
(4
):369
–72
. 22.
Petric
J
, Bright
T
, Liu
DS
, Wee Yun
M
, Watson
DI
. Sutured versus mesh-augmented hiatus hernia repair: a systematic review and meta-analysis of randomized controlled trials
. Ann Surg
. 2022
;275
(1
):e45
–51
. 23.
Watson
DI
, Thompson
SK
, Devitt
PG
, Aly
A
, Irvine
T
, Woods
SD
, et al. Five year follow-up of a randomized controlled trial of laparoscopic repair of very large hiatus hernia with sutures versus absorbable versus nonabsorbable mesh
. Ann Surg
. 2020
;272
(2
):241
–7
. 24.
Buckley
FP
, Havemann
B
, Chawla
A
. Magnetic sphincter augmentation: optimal patient selection and referral care pathways
. World J Gastrointest Endosc
. 2019
;11
(8
):472
–6
. 25.
Richter
JE
, Dempsey
DT
. Laparoscopic antireflux surgery: key to success in the community setting
. Am J Gastroenterol
. 2008
;103
(2
):289
–91
. 26.
Bonavina
L
, Fisichella
PM
, Gavini
S
, Lee
YY
, Tatum
RP
. Clinical course of gastroesophageal reflux disease and impact of treatment in symptomatic young patients
. Ann N Y Acad Sci
. 2020
;1481
(1
):117
–26
. 27.
Labenz
J
, Chandrasoma
PT
, Knapp
LJ
, DeMeester
TR
. Proposed approach to the challenging management of progressive gastroesophageal reflux disease
. World J Gastrointest Endosc
. 2018
;10
(9
):175
–83
. 28.
Bonavina
L
, Boyle
N
, Schoppmann
SF
. The role of magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease
. Curr Opin Gastroenterol
. 2021
;37
(4
):384
–9
. 29.
Guidozzi
N
, Wiggins
T
, Ahmed
AR
, Hanna
GB
, Markar
SR
. Laparoscopic magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: systematic review and pooled analysis
. Dis Esophagus
. 2019
;32
(9
):doz031
. 30.
Bonavina
L
, Horbach
T
, Schoppmann
SF
, DeMarchi
J
. Three-year clinical experience with magnetic sphincter augmentation and laparoscopic fundoplication
. Surg Endosc
. 2021
;35
(7
):3449
–58
. 31.
Bologheanu
M
, Matic
A
, Feka
J
, Asari
R
, Bologheanu
R
, Riegler
FM
, et al. Severe dysphagia is rare after magnetic sphincter augmentation
. World J Surg
. 2022
;46
(9
):2243
–50
. 32.
Stephan
D
, Borbely
Y
, Schoppmann
SF
. RefluxStop therapy: a new minimally invasive technology in anti-reflux surgery
. Surg Technol Int
. 2022
;41
. 33.
Bjelovic
M
, Harsányi
L
, Altorjay
Á
, Kincses
Z
, Forsell
P
, Investigators of the RefluxStop™ Clinical Investigation Study Group
. Non-active implantable device treating acid reflux with a new dynamic treatment approach: 1-year results : RefluxStop device; a new method in acid reflux surgery obtaining CE mark
. BMC Surg
. 2020
;20
(1
):159
. 34.
Harper
S
, Grodzicki
L
, Mealing
S
, Gemmill
E
, Goldsmith
P
, Ahmed
A
. Budget impact of RefluxStop as a treatment for patients with refractory gastro-oesophageal reflux disease in the United Kingdom
. J Health Econ Outcomes Res
. 2024
;11
(1
):1
–7
. 35.
Hill
LD
, Kozarek
RA
, Kraemer
SJ
, Aye
RW
, Mercer
CD
, Low
DE
, et al. The gastroesophageal flap valve: in vitro and in vivo observations
. Gastrointest Endosc
. 1996
;44
(5
):541
–7
. 36.
Koch
OO
, Spaun
G
, Antoniou
SA
, Rabl
C
, Köhler
G
, Emmanuel
K
, et al. Endoscopic grading of the gastroesophageal flap valve is correlated with reflux activity and can predict the size of the esophageal hiatus in patients with gastroesophageal reflux disease
. Surg Endosc
. 2013
;27
(12
):4590
–5
. 37.
Guo
ZWY
, Zhan Y
ZC
. Correlation between gastroesophageal flap valve abnormality and novel parameters in patients with gastroesophageal reflux disease symptoms by the lyon consensus
. Sci Rep
. 2021
;23
(1
):15076
.38.
Shen
S
, Yu
G
, Guo
X
, Zong
G
, Wang
C
, Bao
J
, et al. The long-term efficacy of transoral incisionless fundoplication with Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease
. Esophagus
. 2023
;20
(3
):581
–6
. 39.
Haseeb
M
, Brown
JRG
, Hayat
U
, Bay
C
, Bain
PA
, Jirapinyo
P
, et al. Impact of second-generation transoral incisionless fundoplication on atypical GERD symptoms: a systematic review and meta-analysis
. Gastrointest Endosc
. 2023
;97
(3
):394
–406 e2
. 40.
Jaruvongvanich
VK
, Matar
R
, Reisenauer
J
, Janu
P
, Mavrelis
P
, Ihde
G
, et al. Hiatal hernia repair with transoral incisionless fundoplication versus Nissen fundoplication for gastroesophageal reflux disease: a retrospective study
. Endosc Int Open
. 2023
;11
(1
):E11
–8
. 41.
Pype
DL
. Laparoscopic hiatal hernia repair with concomitant transoral incisionless fundoplication
. AORN J
. 2023
;117
(3
):149
–58
. 42.
Ghosh
G
, Choi
AY
, Dbouk
M
, Greenberg
J
, Zarnegar
R
, Murray
M
, et al. Transoral incisionless fundoplication for recurrent symptoms after laparoscopic fundoplication
. Surg Endosc
. 2023
;37
(5
):3701
–9
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
